9% YTD Return Leaves Chesnara (LSE:CSN) Looking Pricey On A 1.5x P S Multiple

With no fresh headline event driving sentiment, Chesnara (LSE:CSN) has still drawn attention after a share price of £3.28 and a year to date total return slightly above 9%.

Recent trading has been softer, with the share price slipping around 7.6% over the past month and edging lower over 7 and 90 days. However, Chesnara’s momentum over longer periods remains firm, supported by a 1-year total shareholder return of 28.25% and a 5-year total shareholder return close to 100%.

Scan Chesnara alongside a curated 4 resilient stocks with low risk scores that has also been holding up through mixed short term moves.

The recent pullback leaves Chesnara trading below average analyst targets, yet the stock’s steady long term return record keeps caution alive. Is that discount signalling opportunity or flagging risks the market is already pricing in?

Preferred Price-to-Sales Multiple of 1.5x: Is it justified?

On a simple sales-based yardstick, Chesnara is trading on a P/S ratio of 1.5x, compared with a peer average around 1x. This points to a richer tag than many similar insurers despite the recent pullback to £3.28.

The P/S multiple compares the company’s market value with its revenue, so a higher figure means investors are paying more for each pound of premiums and fee income. For a life and pensions group like Chesnara, that kind of valuation often reflects confidence in the stability of its book, the quality of its underwriting, or expectations for future profitability rather than rapid top line expansion.

Here, the picture is mixed. CSN has only recently moved back into profit and its Return on Equity is currently low at 0.2%, while forecasts point to earnings growth of 28.3% per year and high quality earnings. That combination suggests the market is already building in a meaningful earnings improvement, so the 1.5x P/S ratio looks punchy rather than cheap compared with both the 1x peer group and the 1.3x wider European insurance sector.

See what the numbers say about this price — find out in our valuation breakdown..

Result: Price-to-sales of 1.5x (OVERVALUED)

Still, the Chesnara story can change quickly if profit growth stalls from the current £1.0m level, or if acquisition driven expansion fails to add value.

Find out about the key risks to this Chesnara narrative.

Next Steps

If the Chesnara story feels finely balanced between promise and concern, that is exactly the point. It puts the next move on you. Act while sentiment is mixed and weigh the 2 key rewards and 1 important warning sign.

Looking for more ideas beyond Chesnara?

If Chesnara has sharpened your focus on risk, reward and valuation, do not stop here. Put that mindset to work across a wider watchlist of possibilities.

• Hunt for mispriced quality by scanning a curated 8 high quality undervalued stocks that filters for solid fundamentals at prices that may not fully reflect them yet.
• Strengthen your income stream by lining up a shortlist of potential high yield payers with the 2 dividend fortresses and compare their resilience side by side.
• Protect your downside first, then focus on potential upside by zeroing in on the list of solid balance sheet and fundamentals (9 results) before the rest of the market pays attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com